Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.
Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.
Every human being has the right to health and new initiatives should be put in place to encourage pharmaceutical companies to ensure that everyone has access to essential medicine, according to a new book from Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.
An instrument currently aboard the International Space Station could grow E.coli bacteria in space, opening a new path to bio-manufacturing drugs during long term space flights.
New Brunswick, N.J. (March 25, 2020) – Stephen K. Burley, director of the RCSB Protein Data Bank headquartered at Rutgers University–New Brunswick, is available for interviews on how to help the free market fight the coronavirus. His viewpoint is published in the journal Nature. “Had drug…
For many years, Pinar Keskinocak has studied how pandemics spread through the nation, how they overburden health care systems, and how they diminish the supply of medications, thus worsening the pandemic. All this also spins off additional medical crises. She…
The improved technique will help explore genetic diseases and benefit drug development. It could also lead to better, safer weed killers.